Connecticut · G0472

Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in Connecticut

Connecticut Medicare Avg
$45.30
1% above national avg
National Medicare Avg
$44.86
All states combined
Billed Charge (CT)
$55.24
What providers submit
Est. Commercial (CT)
$115.53
National avg: $100.48
Est. Cash / Self-Pay (CT)
$49.17
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

744
Services in CT
141
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Connecticut

Provider Medicare Services
Starling Physicians, Pllc $45.42 155
Licata, Charles DO $45.42 49

Connecticut Pricing in Context

In Connecticut, CPT code G0472 (Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s)) carries an average Medicare payment of $45.30 — 1% above the national benchmark of $44.86. 141 providers across the state submitted claims for this procedure in 2023, performing 744 total services. Individual payments in CT ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Connecticut is $55.24, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Connecticut sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Preventive Screening procedures, the estimated commercial insurance price in Connecticut lands near $115.53, with self-pay cash prices typically around $49.17. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cost in Connecticut?

The average Medicare payment for Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in Connecticut is $45.30, which is 1% above the national average of $44.86. Providers in CT typically bill $55.24 for this procedure.

What does Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cost with insurance in Connecticut?

With commercial insurance in Connecticut, Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) costs an estimated $115.53. Without insurance, the estimated cash price is $49.17. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in Connecticut?

141 providers in Connecticut billed Medicare for Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in 2023, performing 744 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cheaper in Connecticut than the national average?

No — Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) costs 1% above the national average in Connecticut. The state average Medicare payment is $45.30 compared to $44.86 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial